Cyrill is an experienced leader in the Pharmaceutical, Biopharmaceutical, Cell & Gene Therapy, and Medical Device industries. He has an impressive background in Manufacturing, R&D, and Quality, with over 20 years of leadership across the Asia, Europe, and North America markets. His expertise lies in leading complex manufacturing organizations, managing large-scale projects, and controlling expansive operational budgets to ensure on-time and within-budget delivery of products.

Prior to his promotion as COO, Cyrill served as Andelyn’s Head of Manufacturing for three years. During his tenure he oversaw the construction and commissioning of the Andelyn Corporate Center (ACC), an impressive 185,000 sq. ft cGMP state-of-the-art manufacturing facility, drove operational set-up of the site, and achieved the successful start-up of GMP AAV production, ensuring targets and deadlines were met for clients. Prior to joining Andelyn, Cyrill held various leadership and executive positions within Quality and Operations at Novartis and CSL Behring. He holds a Bachelor’s Degree in Chemical Engineering from the University of Basel in Switzerland and a Master of Business Administration specializing in Business Analytics from Syracuse University.